Turmeric compound tested to tame blood cancer symptoms

NCT ID NCT06063486

Recruiting now Symptom relief Sponsor: University of Southern California Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial tests whether a curcumin supplement (C3 complex with piperine) can reduce inflammation and improve symptoms in people with certain blood disorders, including CCUS, low-risk MDS, and MPNs. Thirty participants will receive either curcumin or a placebo for 12 months. Researchers will measure changes in inflammatory markers and symptom scores.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: curcumin supplement (C3 complex with piperine)
What this could lead to: If it works, this could point toward a natural way to reduce inflammation and ease symptoms for people with certain blood disorders.
What could go wrong: This is a small, early-phase trial with only 30 participants, so results may not apply broadly. Curcumin is generally safe but may cause mild stomach upset.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired polycythemia vera essential thrombocythemia myelodysplastic syndrome Myelodysplastic Syndromes myelofibrosis primary myelofibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE ESSENTIAL THROMBOCYTHEMIA MYELODYSPLASTIC SYNDROME MYELOFIBROSIS POLYCYTHEMIA VERA

Contacts and locations

Locations

Los Angeles General Medical Center
RECRUITING

Los Angeles, California, 90033, United States
USC / Norris Comprehensive Cancer Center
RECRUITING

Los Angeles, California, 90033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.